Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia

Elevated serum uric acid is a cardiovascular risk factor in patients with hypertension, even when blood pressure (BP) is well controlled. Xanthine oxidoreductase inhibitors (XORi) reduce serum uric acid levels and have several other potential effects. This multicenter, randomized, open‐label study c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Hypertens (Greenwich)
Main Authors: Kario, Kazuomi, Nishizawa, Masafumi, Kiuchi, Mari, Kiyosue, Arihiro, Tomita, Fumishi, Ohtani, Hiroshi, Abe, Yasuhisa, Kuga, Hideyo, Miyazaki, Satoshi, Kasai, Takatoshi, Hongou, Makiko, Yasu, Takanori, Kuramochi, Jin, Fukumoto, Yoshihiro, Hoshide, Satoshi, Hisatome, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Hyperuricemia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029836/
https://ncbi.nlm.nih.gov/pubmed/33400348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados